AU9541398A - Method for measuring the association of substructures of pathological protein deposits - Google Patents

Method for measuring the association of substructures of pathological protein deposits

Info

Publication number
AU9541398A
AU9541398A AU95413/98A AU9541398A AU9541398A AU 9541398 A AU9541398 A AU 9541398A AU 95413/98 A AU95413/98 A AU 95413/98A AU 9541398 A AU9541398 A AU 9541398A AU 9541398 A AU9541398 A AU 9541398A
Authority
AU
Australia
Prior art keywords
pathological protein
depositions
substructures
protein depositions
association
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU95413/98A
Other languages
English (en)
Inventor
Jan Bieschke
Manfred Eigen
Martin Pitschke
Karin Post
Detlev Riesner
Oliver Schafer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Evotec Biosystems GmbH
Original Assignee
Evotec Biosystems GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1997152712 external-priority patent/DE19752712C2/de
Application filed by Evotec Biosystems GmbH filed Critical Evotec Biosystems GmbH
Publication of AU9541398A publication Critical patent/AU9541398A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
AU95413/98A 1997-09-19 1998-09-18 Method for measuring the association of substructures of pathological protein deposits Abandoned AU9541398A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
DE19741486 1997-09-19
DE19741486 1997-09-19
DE1997152712 DE19752712C2 (de) 1997-11-28 1997-11-28 Verfahren zur Messung der Assoziation von Teilstrukturen pathologischer Proteinablagerungen
DE19752712 1997-11-28
DE19818917 1998-04-28
DE19818917 1998-04-28
PCT/EP1998/005958 WO1999015903A1 (de) 1997-09-19 1998-09-18 Verfahren zur messung der assoziation von teilstrukturen pathologischer proteinablagerungen

Publications (1)

Publication Number Publication Date
AU9541398A true AU9541398A (en) 1999-04-12

Family

ID=27217757

Family Applications (1)

Application Number Title Priority Date Filing Date
AU95413/98A Abandoned AU9541398A (en) 1997-09-19 1998-09-18 Method for measuring the association of substructures of pathological protein deposits

Country Status (7)

Country Link
US (1) US6498017B2 (enExample)
EP (1) EP1015888B1 (enExample)
JP (1) JP4223681B2 (enExample)
AT (1) ATE223058T1 (enExample)
AU (1) AU9541398A (enExample)
DE (1) DE59805338D1 (enExample)
WO (1) WO1999015903A1 (enExample)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001023894A1 (de) * 1999-09-28 2001-04-05 Evotec Oai Ag Quantitative analyse und typisierung subzellulärer partikel
DE19952955A1 (de) * 1999-11-03 2001-05-17 Acgt Progenomics Ag Verfahren zur Charakterisierung und zur Auftrennung von molekularen Assoziaten
DE10013854A1 (de) * 2000-03-17 2001-09-20 Zeiss Carl Jena Gmbh Anordnung und Verfahren zur Untersuchung von Wirkstoffen zur Beeinflussung intrazellulärer Vorgänge
US7640062B2 (en) 2000-05-08 2009-12-29 Brainsgate Ltd. Methods and systems for management of alzheimer's disease
US7146209B2 (en) * 2000-05-08 2006-12-05 Brainsgate, Ltd. Stimulation for treating eye pathologies
US6603546B1 (en) * 2000-07-21 2003-08-05 I.S.S. (Usa) Inc. Rapid high throughput spectrometer and method
JP4235544B2 (ja) * 2001-05-31 2009-03-11 アドライフ インコーポレーティッド 欠陥折畳み蛋白質センサー方法
US20050026165A1 (en) * 2001-05-31 2005-02-03 Cindy Orser Detection of conformationally altered proteins and prions
EP1321771A1 (de) * 2001-12-21 2003-06-25 Evotec Analytical Systems GmbH Verfahren zur qualitativen und/oder quantitativen Bestimmung von Aggregaten
EP2301959A3 (en) * 2002-04-09 2013-03-13 The Scripps Research Institute Motif-grafted hybrid polypeptides and uses thereof
CA2483635A1 (en) * 2002-04-25 2003-11-06 Alon Shalev Methods and apparatus for modifying properties of the bbb and cerebral circulation by using the neuroexcitatory and/or neuroinhibitory effects of odorants on nerves in the head
US7684859B2 (en) * 2002-04-25 2010-03-23 Brainsgate Ltd. Stimulation of the OTIC ganglion for treating medical conditions
JP2006515999A (ja) * 2002-11-14 2006-06-15 ブレインズゲート リミティド 刺激のための外科用ツール及び技法
WO2005008212A2 (en) * 2003-06-20 2005-01-27 The Regents Of The University Of California Modulated excitation fluorescence analysis
US20060035242A1 (en) * 2004-08-13 2006-02-16 Michelitsch Melissa D Prion-specific peptide reagents
EP1600774A1 (de) * 2004-03-12 2005-11-30 Ludwig-Maximilians-Universität München Verfahren zur Identifizierung von Substanzen zur Beeinflussung der Aggregationen von Proteinen
US8055347B2 (en) 2005-08-19 2011-11-08 Brainsgate Ltd. Stimulation for treating brain events and other conditions
US8010189B2 (en) * 2004-02-20 2011-08-30 Brainsgate Ltd. SPG stimulation for treating complications of subarachnoid hemorrhage
US9233245B2 (en) 2004-02-20 2016-01-12 Brainsgate Ltd. SPG stimulation
JP4338590B2 (ja) 2004-06-03 2009-10-07 独立行政法人科学技術振興機構 蛍光相関分光法による抗原の迅速検出及び／又は測定法。
WO2006021957A2 (en) * 2004-08-23 2006-03-02 Brainsgate Ltd. Concurrent bilateral spg modulation
US20060057671A1 (en) * 2004-09-10 2006-03-16 Orser Cindy S Immobilized probes and methods of detecting conformationally altered prion proteins
WO2006076683A2 (en) * 2005-01-13 2006-07-20 Novartis Vaccines And Diagnostics Inc. Isolation and detection of pathogenic prions
WO2006076687A2 (en) * 2005-01-13 2006-07-20 Novartis Vaccines And Diagnostics Inc. Elisa assays using prion-specific peptide reagents
BRPI0607350A2 (pt) * 2005-02-15 2009-09-01 Adlyfe Inc método para detecção da presença ou quantidade de uma proteìna erroneamente duplicada em uma amostra e kit
US20090253217A1 (en) 2005-09-12 2009-10-08 Japan Science And Technology Agency Method of Quickly Detecting Antigen Using Fluorescence Correlation Spectroscopy or Fluorescence Cross-Correlation Spectroscopy
ATE426174T1 (de) * 2006-07-28 2009-04-15 Vista Ventures Gmbh Verfahren zum nachweis der amyloid-beta oligomere in kírperflussigkeiten
EP2156181B1 (en) * 2006-07-28 2015-11-04 Adlyfe, Inc. Peptide probes for diagnostics and therapeutics
WO2008022035A2 (en) * 2006-08-10 2008-02-21 The Scripps Research Institute Methods for identifying cellular modulators of disaggregation activity or aggregation activity in an animal
US20090210026A1 (en) * 2006-08-17 2009-08-20 Brainsgate Ltd. Spg stimulation for enhancing neurogenesis and brain metabolism
JP2010043865A (ja) * 2006-12-12 2010-02-25 Olympus Corp 異常型プリオンの検出方法
US7860569B2 (en) 2007-10-18 2010-12-28 Brainsgate, Ltd. Long-term SPG stimulation therapy for prevention of vascular dementia
JP2011520108A (ja) * 2008-04-30 2011-07-14 ノバルティス アーゲー 病原性配座異性体についてのアッセイ
US20110174064A1 (en) * 2008-10-02 2011-07-21 Ramot At Tel-Aviv University Ltd. Method and system for emitting light
US20100129290A1 (en) * 2008-11-26 2010-05-27 I.S.T. Corporation Smart contrast agent and detection method for detecting transition metal ions
US20100227794A1 (en) * 2008-11-26 2010-09-09 I.S.T. Corporation Smart contrast agent and method for detecting transition metal ions and treating related disorders
US10512794B2 (en) 2016-12-16 2019-12-24 Brainsonix Corporation Stereotactic frame
US10974078B2 (en) 2012-12-27 2021-04-13 Brainsonix Corporation Treating degenerative dementia with low intensity focused ultrasound pulsation (LIFUP) device
US9061133B2 (en) 2012-12-27 2015-06-23 Brainsonix Corporation Focused ultrasonic transducer navigation system
US9675796B2 (en) 2013-11-10 2017-06-13 Brainsgate Ltd. Implant and delivery system for neural stimulator
EP3093043B1 (en) 2015-05-13 2018-11-14 Brainsgate Ltd. Implant and delivery system for neural stimulator
WO2018112269A1 (en) * 2016-12-15 2018-06-21 Brainsonix Corporation Treating degenerative dementia using low intensity focused ultrasound pulsation (lifup) device
GB201805466D0 (en) * 2018-04-03 2018-05-16 Vukojevic Vladana Methods
US11759661B2 (en) 2020-05-20 2023-09-19 Brainsonix Corporation Ultrasonic transducer treatment device
US12257446B2 (en) 2020-08-24 2025-03-25 Brainsonix Corporation Systems and methods for neuromodulation of neuronal circuits using transcranial focused microwave pulses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05506990A (ja) * 1990-04-24 1993-10-14 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア プロテアーゼ　ネキシン―２の精製、検出、及び使用方法
AU4376093A (en) * 1992-05-15 1993-12-13 Instituto Nazionale Neurologico C. Besta Soluble prion polypeptides, and methods for detecting and purifying thereof
DE852011T1 (de) 1995-09-14 2001-10-11 Scripps Res Inst La Jolla Für natives prp-sc spezifische antikörper
US6426409B1 (en) * 1995-10-26 2002-07-30 Ernst-Ludwig Winnacker Nucleic acid molecules that bind prion proteins and processes for the production thereof

Also Published As

Publication number Publication date
US6498017B2 (en) 2002-12-24
US20020042121A1 (en) 2002-04-11
WO1999015903A1 (de) 1999-04-01
JP2001517800A (ja) 2001-10-09
DE59805338D1 (de) 2002-10-02
JP4223681B2 (ja) 2009-02-12
EP1015888A1 (de) 2000-07-05
ATE223058T1 (de) 2002-09-15
EP1015888B1 (de) 2002-08-28

Similar Documents

Publication Publication Date Title
AU9541398A (en) Method for measuring the association of substructures of pathological protein deposits
NZ333744A (en) Immunological process for detecting antibodies directed towards tissue transglutaminase (ttg), use of ttg for diagnostic purposes and therapy control, and oral pharmaceutical agent containing ttg
WO2004063753A3 (en) A serum marker for measuring liver fibrosis
WO2004063682A3 (en) Systems and methods for monitoring speed
EP1076475A3 (en) Heating apparatus for cooking
CA2072314A1 (en) Methods for detection of carcinoma metastases by nucleic acid amplification
DK0968421T3 (da) Diagnose af tidlig gastrisk cancer
WO2003048333A3 (en) Endorepellin compositions and methods for inhibiting angiogenesis
Thurner et al. The molecular basis for development of proinflammatory autoantibodies to progranulin
DE69637909D1 (de) ANTI-Fas-LIGAND ANTIKÖRPER UND TESTMETHODE UNTER VERWENDUNG DERSELBEN
Strittmatter et al. Characterization of angiotensin converting enzyme by [3H] captopril binding.
AU5146896A (en) Assaying protein fragments in body fluids
FR2816411B1 (fr) Moyens de detection de la transformation pathologique de la proteine app et leurs applications
Umphress et al. Determinants on simian virus 40 large T antigen are important for recognition and phosphorylation by casein kinase I
US11236381B2 (en) Method for checking and controlling the mammalian lactic acid fermentation process/aerobic glucose fermentation metabolic pathway in mammalian organism
You et al. Proteolytic targeting of transcriptional regulator TIP120B by a HECT domain E3 ligase
Schutgens et al. 118: MULTIPLE PEROXISOMAL ENZYME DEFICIENCIES IN RHIZOMELIC CHONDRODYSPLASIA PUNCTATA
WO2000055354A3 (en) A diagnostic test
Osuga et al. Modification of galactose and N-acetylgalactosamine residues by oxidation of C-6 hydroxyls to the aldehydes followed by reductive amination: Model systems and antifreeze glycoproteins
US20030148491A1 (en) Density enhanced protein tyrosine phosphatases
Leandro et al. The serum tissue polypeptide antigen in the detection of hepatocellular carcinoma in cirrhotic patients
Hoeks et al. An effective algorithm for measuring diastolic artery diameters
WO2004099784A3 (en) Method for determining a tissue degradation process by detection of fibromodulin neoepitopes
Kim et al. Splenomegaly: splenic volume measurement by ultrasound, validity and reliability, clinical implications in liver cirrhosis: 391
DE69307707D1 (de) TESTSYSTEM FüR DEGENERATIVE MUSKELERKRANKUNGEN

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase